INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

2,768 studies · page 26 of 116

2016 / Randomized controlled trial

Adding extended-release niacin with laropiprant to statin therapy reduced quality-adjusted life years and increased hospital costs over 4 years.

In the HPS2-THRIVE trial, 25,673 participants aged 50 to 80 years with prior cardiovascular disease receiving statin therapy were randomized to 2 g extended-release niacin with 40 mg laropiprant daily or placebo for 4 years. Participants assigned to niacin-laropiprant experienced non-significantly lower survival (0.012 fewer years [SE 0.007]), significantly fewer quality-adjusted life years (0.023 [SE 0.007] fewer using UK EQ-5D; 0.020 [SE 0.006] fewer using US EQ-5D), and higher hospital costs (UK £101 [SE £37]; US $145 [SE $53]). Stroke, heart failure, musculoskeletal, gastrointestinal, and infection events were associated with substantial declines in quality of life and increased hospital costs.

Kent S, Haynes R, Hopewell JC, et al. Circ Cardiovasc Qual Outcomes, 2016. PMID 27407053

2016 / 4-arm randomized controlled trial

Caloric restriction with or without exercise significantly reduced circulating angiogenic biomarkers in overweight postmenopausal women.

A 12-month trial randomized 439 overweight/obese postmenopausal women to caloric restriction diet, aerobic exercise, combined diet + exercise, or control. Diet + exercise significantly reduced PAI-1 compared to control (-19.3% vs. +3.48%, P < 0.0001). Both the diet and combined arms showed significant reductions versus controls in PEDF (-9.20% and -9.90%, both P < 0.0001) and VEGF (-8.25%, P = 0.0005; -9.98%, P < 0.0001). Exercise alone produced no differences in any analyte versus control, while greater weight loss linearly correlated with larger biomarker reductions.

Duggan C, Tapsoba Jde D, Wang CY, et al. Cancer Res, 2016. PMID 27417562

2016 / Randomized, double-blind crossover trial

Distal, but not proximal, colonic acetate infusions increased fasting fat oxidation and PYY in overweight or obese men.

Six overweight/obese men underwent two experimental periods with endoscopically placed catheters for distal and proximal colonic infusions of sodium acetate (100 or 180 mmol/l) or placebo across fasting and postprandial conditions. Distal colonic 180 mmol/l acetate infusions significantly increased fasting fat oxidation (1.78±0.28 vs. -0.78±0.89 g fat 2 h-1, P=0.015), fasting PYY (P=0.01), and postprandial glucose and insulin levels (P<0.05) compared to placebo. Distal 100 mmol/l acetate tended to decrease fasting TNF-α (P=0.067). In contrast, proximal colonic acetate infusions had no observed effects on substrate metabolism, circulating hormones, or inflammatory markers.

van der Beek CM, Canfora EE, Lenaerts K, et al. Clin Sci (Lond), 2016. PMID 27439969

2016 / Randomized controlled trial

Fig paste reduced colon transit time and improved symptoms in functional constipation.

A randomized, double-blind, placebo-controlled trial evaluated 8 weeks of Ficus carica paste versus placebo in 80 Korean participants with functional constipation. Supplementation significantly decreased colon transit time compared with placebo. Fig paste also significantly improved stool consistency and abdominal discomfort, while organ toxicity markers and blood parameters remained within normal ranges.

Baek HI, Ha KC, Kim HM, et al. Asia Pac J Clin Nutr, 2016. PMID 27440682

2016 / Randomized controlled trial

Tart cherry concentrate improved recovery and reduced muscle soreness after strenuous intermittent exercise

Sixteen semi-professional male soccer players consumed 30 mL of Montmorency tart cherry concentrate or placebo twice daily for eight days surrounding an intermittent shuttle test. Supplementation accelerated recovery of isometric contraction, jump performance, and agility, while also lowering muscle soreness ratings (p < 0.05). Tart cherry intake also attenuated post-exercise interleukin-6 increases, though it showed no significant effects on lipid hydroperoxides or creatine kinase levels.

Bell PG, Stevenson E, Davison GW, et al. Nutrients, 2016. PMID 27455316

2016 / Randomized controlled crossover study and in vitro fermentations

Inulin-propionate ester (IPE-27) significantly reduced ad libitum energy intake compared with inulin control and IPE-54 in a crossover trial.

Researchers developed inulin short-chain fatty acid esters to deliver propionate directly to the colon and tested them in vitro and in humans. In a randomized controlled crossover study, participants received 10 g/day of IPE-27, IPE-54, or inulin control for 7 days. In vivo, IPE-27 produced greater 13C recovery in breath CO2 than IPE-54 (64.9 vs. 24.9%, P = 0.001) and reduced energy intake during an ad libitum test meal compared with inulin (439.5 vs. 703.9 kcal, P = 0.025) and IPE-54 (439.5 vs. 659.3 kcal, P = 0.025). Intake with IPE-54 did not differ significantly from inulin control.

Polyviou T, MacDougall K, Chambers ES, et al. Aliment Pharmacol Ther, 2016. PMID 27464984

2016 / Double-blind, randomized, placebo-controlled trial

In sedentary adults, daily dark chocolate intake for 3 months increased maximum work, improved muscle markers, and raised HDL levels.

Twenty sedentary adults aged ~50 were randomized to consume 20 g of dark chocolate or placebo daily for 3 months, with 17 completing the study. In the dark chocolate group (n = 9), VO2 max showed a 17% increase (p = 0.056) and maximum work achieved increased significantly (p = 0.026), alongside higher HDL (p = 0.005) and decreased triglycerides (p = 0.07), with no changes in placebo (n = 8). Skeletal muscle showed significant increases in LKB1, AMPK, and PGC1α proteins and their active forms, citrate synthase activity, and reduced glutathione, as well as decreased protein carbonylation, without changes in mitochondrial density. The authors note larger clinical studies are warranted to confirm these observations.

Taub PR, Ramirez-Sanchez I, Patel M, et al. Food Funct, 2016. PMID 27491778

2016 / Randomized controlled trial

Flaxseed reduced central blood pressure in participants with high baseline blood pressure.

Among 62 patients with peripheral artery disease who had high blood pressure at baseline, dietary flaxseed lowered central systolic and diastolic blood pressures by an average of 10 and 6 mm Hg compared to placebo. Flaxseed did not significantly alter the augmentation index or other cardiac function indices. The reduction in central blood pressure was linked to decreases in specific plasma oxylipins, including 16-hydroxyeicosatetraenoic acid and thromboxane B2.

Caligiuri SP, Rodriguez-Leyva D, Aukema HM, et al. Hypertension, 2016. PMID 27528063

2016 / Randomized, placebo-controlled, double-blind parallel study

Vaccinium uliginosum extract (1000 mg/day for 4 weeks) alleviated tablet computer-induced asthenopia symptoms.

A total of 60 volunteers were randomized to receive either 1000 mg/day of Vaccinium uliginosum extract (DA9301) or a placebo for 4 weeks to examine effects on tablet computer-induced asthenopia. At baseline, the total asthenopia score (TAS) increased significantly after tablet watching in the DA9301 group (from 20.35 to 23.88; p = 0.031), but remained stable after tablet watching following 4 weeks of supplementation. In the control group, TAS changes induced by tablet watching were not significant at either baseline or 4 weeks. Individual symptom scores for tired eyes, sore/aching eyes, irritated eyes, watery eyes, dry eyes, eye strain, blurred vision, and visual discomfort significantly improved in the DA9301 group.

Park CY, Gu N, Lim CY, et al. BMC Complement Altern Med, 2016. PMID 27538497

2016 / Intervention study (mice and humans)

Dietary protein dilution increases serum markers of metabolic health in mice and humans and improves glucose homeostasis in mice via an NEAA/NUPR1/FGF21 axis.

Investigators studied the effects of dietary protein dilution (DPD) on metabolic health markers in mice and humans, as well as its mechanistic pathways in murine models. DPD increased serum markers of metabolic health in both mice and humans. In lean mice, DPD promoted metabolic inefficiency by increasing carbohydrate and fat oxidation, and in murine models of obesity, it prevented and curtailed impaired glucose homeostasis independently of obesity and food intake. The metabolic improvements required liver-derived FGF21, induced by liver-integrated stress response-driven NUPR1 triggered by insufficiency of select nonessential amino acids.

Maida A, Zota A, Sjøberg KA, et al. J Clin Invest, 2016. PMID 27548521

2016 / Randomized controlled experiment

Informing people they burned more calories during exercise led to greater subsequent energy intake, mostly from cookies.

Seventy healthy, mostly lean men and women completed an exercise bout (estimated energy expenditure 120 kcal) and were informed that they had expended either 50 kcal or 265 kcal. Participants then received an ad libitum test meal containing orange juice, tortilla chips, and chocolate chip cookies. Greater energy intake, primarily driven by chocolate chip cookie consumption (p = 0.015), occurred in the 265 kcal group. Hunger ratings were significantly lower in the 265 kcal information group compared with the 50 kcal group after the test meal (p = 0.035), but not immediately after exercise.

McCaig DC, Hawkins LA, Rogers PJ Appetite, 2016. PMID 27554186

2016 / Randomized controlled trial

Alternate-day fasting and daily caloric restriction produced similar 8-week weight loss in obesity.

A randomized pilot trial assigned 26 adults with obesity to 8 weeks of zero-calorie alternate-day fasting or daily calorie restriction (-400 kcal/day). Weight loss did not differ significantly between groups at 8 weeks (-8.2 ± 0.9 kg for fasting vs -7.1 ± 1.0 kg for restriction), nor were there differences in lipids, body composition, or insulin sensitivity. After 24 weeks of unsupervised follow-up, weight regain was similar between groups.

Catenacci VA, Pan Z, Ostendorf D, et al. Obesity (Silver Spring), 2016. PMID 27569118

2016 / Randomized controlled trial

Eating the main meal at lunch rather than dinner enhanced weight loss

In a 12-week trial of 80 overweight and obese women in a weight-loss program, 69 completed allocating their main energy intake to lunch or dinner. The lunch group achieved greater reductions in weight (-5.85 kg vs. -4.35 kg; P = 0.003), body mass index (P = 0.003), fasting insulin (P < 0.001), and insulin resistance (P = 0.001) than the dinner group. Fasting glucose and lipid profiles did not differ between groups.

Madjd A, Taylor MA, Delavari A, et al. Am J Clin Nutr, 2016. PMID 27581472

2016 / Repeated-measures experimental study

In healthy women, 18-hour fasting increased irritability as well as feelings of achievement, reward, pride, and control.

A repeated-measures study evaluated affective responses to an 18-hour fasting period compared to a non-fasting period in 52 healthy women (mean age 25). Participants completed diary measures tracking self-reported psychological variables throughout both conditions. Fasting led to increased irritability, alongside positive affective experiences including an increased sense of achievement, reward, pride, and control.

Watkins E, Serpell L Front Nutr, 2016. PMID 27597946

2016 / Randomized controlled trial

A routine cold shower reduced self-reported sickness absence from work by 29% but did not significantly change total illness days.

Participants aged 18 to 65 were randomized to a hot-to-cold shower lasting 30, 60, or 90 seconds, or to a control group, for 30 consecutive days followed by 60 days of optional cold showering. A negative binomial regression model showed a 29% reduction in sickness absence from work for the cold shower regimen compared to controls (incident rate ratio: 0.71, P = 0.003). There was no significant group effect on total illness days, and no related serious adverse events were reported.

Buijze GA, Sierevelt IN, van der Heijden BC, et al. PLoS One, 2016. PMID 27631616

2016 / Double-blind, placebo-controlled randomized clinical trial

Daily probiotic treatment with Lactobacillus casei Shirota accelerated functional recovery in elderly patients with a distal radius fracture.

A total of 417 elderly patients with an acute distal radius fracture were randomized to receive skimmed milk containing either Lactobacillus casei Shirota or placebo daily for 6 months. Throughout the study, patients receiving probiotics showed a significantly faster pace of improvement in DASH score, pain, CRPS score, wrist flexion, and grip strength compared to placebo. Treatment outcomes for the probiotic group at month 4 were comparable to levels seen in the placebo group at month 6.

Lei M, Hua LM, Wang DW Benef Microbes, 2016. PMID 27633174

2016 / Randomized crossover trial

A high-fiber meal led to a slightly greater reduction in organoleptically assessed oral halitosis than a low-fiber meal in 20 subjects.

In a randomized clinical crossover study, 20 subjects were evaluated over 2.5 hours following the consumption of a high-fiber meal versus a low-fiber control meal. Both the test and control phases showed statistically significant reductions in volatile sulfur compounds, organoleptic assessment, tongue coating, and subjective mouth sensation (p<0.05). However, a statistically significantly higher reduction after the high-fiber meal compared to the control meal was observed only for the organoleptic assessment of halitosis (p<0.05).

Wälti A, Lussi A, Seemann R Swiss Dent J, 2016. PMID 27655031

2016 / Randomized, double-blind, placebo-controlled pilot study

Resveratrol supplementation significantly reduced disease activity and improved oxidative stress markers in patients with active ulcerative colitis.

Fifty-six patients with active mild to moderate ulcerative colitis were randomized to receive either 500 mg/day resveratrol capsules or placebo for 6 weeks. In the resveratrol group, serum SOD increased from 122.28 ± 11.55 to 125.77 ± 10.97, TAC increased from 9.87 ± 1.51 to 11.97 ± 1.61, and serum MDA decreased from 5.62 ± 1.18 to 3.42 ± 1.01 (p < 0.001). In addition, resveratrol supplementation significantly decreased disease activity and improved quality of life compared to baseline (p < 0.001).

Samsamikor M, Daryani NE, Asl PR, et al. Arch Med Res, 2016. PMID 27664491

2016 / Randomized crossover trial

Acute açai smoothie consumption improved flow-mediated dilatation and reduced oxidative status in men.

In a randomized double-blind crossover trial of 23 overweight men given a high-fat breakfast challenge, an açai smoothie increased flow-mediated dilatation by 1.4% at 2 hours and 0.8% at 6 hours, versus 0.4% and -0.3% for control. The açai beverage also lowered postprandial total peroxide oxidative status. Blood pressure, heart rate, and glucose remained unchanged, whereas early insulin peaks and overall post-meal insulin exposure were higher following açai.

Alqurashi RM, Galante LA, Rowland IR, et al. Am J Clin Nutr, 2016. PMID 27680990

2016 / Randomized controlled trial

Adding navy bean powder or rice bran was feasible, well tolerated, and significantly increased dietary fiber intake in colorectal cancer survivors.

Twenty-nine colorectal cancer survivors completed a randomized controlled trial receiving foods with cooked navy bean powder (35 g/day), heat-stabilized rice bran (30 g/day), or no added ingredient. The consumed amounts represented 4-9% of daily caloric intake, with no major gastrointestinal issues reported. Dietary fiber significantly increased in both the navy bean and rice bran groups at Weeks 2 and 4 compared with baseline and control (P <= 0.01). Telomere length correlated with age and HDL cholesterol at baseline, and with improved serum amyloid A levels at Week 4 (P <= 0.05).

Borresen EC, Brown DG, Harbison G, et al. Nutr Cancer, 2016. PMID 27689688

2016 / Clinical trial

Higher protein during weight loss prevented improvements in muscle insulin sensitivity in women.

A clinical trial examined postmenopausal women with obesity undergoing approximately 10% weight loss on hypocaloric diets containing either 0.8 g or 1.2 g protein/kg/day. The higher-protein diet reduced lean tissue loss by roughly 45%. However, higher protein intake also eliminated the weight-loss-induced gains in muscle insulin signaling and insulin-stimulated glucose uptake, while preventing cellular adaptations in oxidative stress pathways.

Smith GI, Yoshino J, Kelly SC, et al. Cell Rep, 2016. PMID 27732859

2016 / Comparative clinical trial

A very low-calorie diet and gastric bypass induced distinct systemic inflammatory changes

Systemic inflammation was assessed three months after gastric bypass (n=15) or a very low-calorie diet (n=12) in morbidly obese women with type 2 diabetes, plus 12 lean controls. Both interventions lowered CRP and leptin while raising adiponectin. However, the diet was linked to reductions in TNF-alpha, IL-2, and IL-6, whereas bypass was linked to increased TNF-alpha and higher numbers of activated cytotoxic T and B cells.

Lips MA, van Klinken JB, Pijl H, et al. Metabolism, 2016. PMID 27733249

2016 / Randomized crossover trial series

A short-term saturated fatty acid-enriched diet rapidly induced whole-body insulin resistance in subjects with normal and impaired glucose tolerance.

Researchers evaluated high-calorie diets enriched with saturated fatty acids (SFA) or carbohydrates (CARB) compared to a standard eucaloric AHA control diet in subjects with NGT or IGT. Steady state plasma glucose (SSPG) increased by 83±74% versus control after a 24-hour SFA diet across the entire cohort (n=38; NGT: 92±82%, n=22; IGT: 65±55%, n=16; all p<0.001) and by 55±32% after a single SFA breakfast (p=0.008, n=7). The SSPG elevation was 24±31% after an overnight fast (p=0.04, n=10) and further attenuated 24 hours after returning to the control diet (19±35%, p=0.09, n=11), while a 24-hour CARB diet did not significantly increase SSPG (26±50%, p=0.11, n=12).

Koska J, Ozias MK, Deer J, et al. Metabolism, 2016. PMID 27733250

2016 / Randomised crossover study

Walking for 10 minutes after each main meal lowered postprandial glycaemia more than walking 30 minutes once daily in adults with type 2 diabetes.

A randomised crossover study evaluated 41 adults with type 2 diabetes mellitus comparing advice to walk 30 minutes each day versus advice to walk 10 minutes after each main meal for 2-week periods. Postprandial glycaemia iAUC over 3 hours post-meal was significantly lower when walking after meals compared with a single daily walk (ratio of geometric means 0.88, 95% CI 0.78, 0.99). The improvement was especially marked after the evening meal (0.78, 95% CI 0.67, 0.91), when carbohydrate consumption was highest. One participant died during the 30-day washout period, an event not judged to be related to study participation.

Reynolds AN, Mann JI, Williams S, et al. Diabetologia, 2016. PMID 27747394